Protection of estrogen in portal hypertension gastropathy - An experimental model;Proteção do estrogênio na gastropatia da hipertensão portal - Um modelo experimental

Arquivos de Gastroenterologia

Volumn 48, Issue 3, 2011, Pages 211-216

  Morgan Martins, Maria Isabel ^a,b   Jacques, Simone Iahnig ^a,b   Hartmann, Renata Minuzzo ^a,b   Marques, Camila Moraes ^a,b   Marroni, Cláudio Augusto ^c   Marroni, Norma Possa ^a,b  

^a UNIVERSIDADE LUTERANA DO BRASIL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

Author keywords

Estrogens; Hypertension; Portal; Rats; Stomach diseases

Indexed keywords

CATALASE; ESTROGEN; GLUTATHIONE PEROXIDASE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CASTRATED FEMALE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; LIPID PEROXIDATION; MESENTERIC VEIN; NONHUMAN; PORTAL HYPERTENSION; PORTAL VEIN BLOOD PRESSURE; RAT; SHAM PROCEDURE; STOMACH; STOMACH DISEASE; VEIN LIGATION; WISTAR RAT;

EID: 80053451027     PISSN: 00042803     EISSN: 16784219     Source Type: Journal    
DOI: 10.1590/S0004-28032011000300011     Document Type: Article

References (41)

1. Baker HJ, Lindsey JR, Weisbroth SH, editors. The laboratory rat. V.I. Biology and diseases. New York: Academic Press; 1979.
2. Bednarek-Tupikowska G, Bohdanowicz-Pawlak A, Bidzinska B, Milewicz A, Antonowicz-Juchniewicz J, Andrzejak R. Serum lipid peroxide levels and erythrocyte glutathione peroxidase and superoxide dismutase activity in premenopausal and postmenopausal women. Gynecol Endocrinol. 2001;15:298-303.
3. Borekci B, Kumtepe Y, Karaca M, Halici Z, Cadirci E, Albayrak F, Polat B, Suleyman H. Role of alpha-2 adrenergic receptors in anti-ulcer effect mechanism of estrogen and luteinising hormone on rats. Gynecol Endocrinol. 2009;25:264-8.
4. Borrás C, Sastre J, García-Sala D, Lloret A, Pallardó FV, Viña J. Mitochondria from females exhibit higher antioxidant gene expression and lower oxidative damage than males. Free Radic Biol Med. 2003;34:546-52.
5. Borrás C, Gambini J, López-Grueso R, Pallardó FV, Viña J. Direct antioxidant and protective effect of estradiol on isolated mitochondria. Biochim Biophys Acta. 2010;1802:205-11.
6. Bosch J, Berzigotti A, Garcia-Pagan JC, Abraldes JG. The management of portal hypertension: rational basis, available treatments and future options. J Hepatol. 2008;48(Suppl 1):s68-92.
7. Boveris A, Chance B. The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen. Biochem J. 1973;134:707-16.
8. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-54.
9. Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol. 1978;52:302-10.
10. Cameron JL, Herlong HF, Sanfey H, Boitnott J, Kaufman SL, Gott VL, Maddrey WC. The Budd-Chiari syndrome. Treatment by mesenteric-systemic venous shunts. Ann Surg. 1983;198:335-46.
11. Cichoz-Lach H, Celinski K, Slomka M, Kasztelan-Szczerbinska B. Pathophysiology of portal hypertension. J Physiol Pharmacol. 2008;59:231-8.
12. Dantas APV, Carvalho MHC. Efecto protector de los estrógenos en el sistema cardiovascular. Antioxid Calid Vida. 2000;7(28):6-11.
13. Fernandes CE, Baracat EC, Lima GR, editors. Climateric: a handbook. São Paulo: Ponto; 2004. 372p.
14. Flohé L, Günzler WA. Assays of glutathione peroxidase. Methods Enzymol. 1984;105:114-21.
15. Gruber CJ, Tschugguel W, Schneeberger C, Huber JC. Production and actions of estrogens. N Engl J Med. 2002;346:340-52.
16. Hayashi T, Fukuto JM, Ignarro LJ, Chaudhuri G. Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis. Proc Natl Acad Sci USA. 1992;89:11259-63.
17. Hernández I, Delgado JL, Díaz J, Quesada T, Teruel MJ, Llanos MC, Carbonell LF. 17beta-estradiol prevents oxidative stress and decreases blood pressure in ovariectomized rats. Am J Physiol Regul Integr Comp Physiol. 2000;279:R1599-R605.
18. Kumtepe Y, Borekci B, Karaca M, Salman S, Alp HH, Suleyman H. Effect of acute and chronic administration of progesterone, estrogen, FSH and LH on oxidant and antioxidant parameters in rat gastric tissue. Chem Biol Interact. 2009;182:1-6.
19. Levin ER. Cellular functions of plasma membrane estrogen receptors. Steroids. 2002;67:471-5.
20. Levin ER. Estrogen receptor-beta and the cardiovascular system. Trends Endocrinol Metab. 2002;13:184-5.
21. Llesuy SF, Milei J, Molina H, Boveris A, Milei S. Comparison of lipid peroxidation and myocardial damage induced by adriamycin and 4'-epiadriamycin in mice. Tumori. 1985;71:241-9.
22. Martinelli ALC. Portal hypertension. Medicina (Ribeirão Preto). 2004; 37: 253-61.
23. McCormack TT, Sims J, Eyre-Brook I, Kennedy H, Goepel J, Johnson AG, Triger DR. Gastric lesions in portal hypertension: inflammatory gastritis or congestive gastropathy? Gut. 1985;26:1226-32.
24. Misra HP, Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem. 1972;247:3170-5.
25. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991;43:109-42.
26. Moreira AJ, Fraga C, Alonso M, Collado PS, Zetller C, Marroni C, Marroni N, González-Gallego J. Quercetin prevents oxidative stress and NF-kappaB activation in gastric mucosa of portal hypertensive rats. Biochem Pharmacol. 2004;68:1939-46.
27. Morgan-Martins MI. Replacement estrogen decreases oxidative damage, increase the activity of antioxidant enzymes and improves cardiac function in rats [thesis]. Porto alegre: Federal University of Rio Grande do Sul; 2003.
28. Niki E, Nakano M. Estrogens as antioxidants. Methods Enzymol. 1990;186:330-3.
29. Ozgönül M, Oge A, Sezer ED, Bayraktar F, Sözmen EY. The effects of estrogen and raloxifene treatment on antioxidant enzymes in brain and liver of ovarectomized female rats. Endocr Res. 2003;29:183-9.
30. Primignani M, Carpinelli L, Preatoni P, Battaglia G, Carta A, Prada A, Cestari R, Angeli P, Gatta A, Rossi A, Spinzi G, De Franchis R. Natural history of portal hypertensive gastropathy in patients with liver cirrhosis. The New Italian Endoscopic Club for the study and treatment of esophageal varices (NIEC). Gastroenterology. 2000;119:181-7.
31. Römer W, Oettel M, Menzenbach B, Droescher P, Schwarz S. Novel estrogens and their radical scavenging effects, iron-chelating, and total antioxidative activities: 17 alpha-substituted analogs of delta 9(11)-dehydro-17 beta-estradiol. Steroids. 1997;62:688-94.
32. Saleh TM, Connell BJ, Saleh MC. Acute injection of 17beta-estradiol enhances cardiovascular reflexes and autonomic tone in ovariectomized female rats. Auton Neurosci. 2000;84:78-88.
33. Sikuler E, Groszmann RJ. Hemodynamic studies in a parabiotic model of portal hypertension. Experientia. 1985;41:1323-4.
34. Sikuler E, Kravetz D, Groszmann RJ. Evolution of portal hypertension and mechanisms involved in its maintenance in a rat model. Am J Physiol. 1985;248:G618-G25.
35. Strehlow K, Rotter S, Wassmann S, Adam O, Grohé C, Laufs K, Böhm M, Nickenig G. Modulation of antioxidant enzyme expression and function by estrogen. Circ Res. 2003;93:170-7.
36. Torrezan R, Gomes RM, Ferrarese ML, de Melo FB, Ramos AM, Mathias PC, Scomparin DX. [Treatment with isoflavones replaces estradiol effect on the tissue fat accumulation from ovariectomized rats]. Arq Bras Endocrinol Metabol. 2008;52:1489-96.
37. Webster NR, Nunn JF. Molecular structure of free radicals and their importance in biological reactions. Br J Anaesth. 1988;60:98-108.
38. Wen Z, Zhang JZ, Xia HM, Yang CX, Chen YJ. Stability of a rat model of prehepatic portal hypertension caused by partial ligation of the portal vein. World J Gastroenterol. 2009;15:4049-54.
39. Wendel A. Glutathione peroxidase. Methods Enzymol. 1981;77:10-5.
40. Yokoyama Y, Baveja R, Sonin N, Clemens MG, Zhang JX. Hepatic neovascularization after partial portal vein ligation: novel mechanism of chronic regulation of blood flow. Am J Physiol Gastrointest Liver Physiol. 2001;280:G21-31.
41. Zhu BT, Conney AH. Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis. 1998 Jan;19:1-27.